The National Health and Care Commission issued important documents affecting hospital medication.

Source/ National Health and Welfare Commission▍ finishing / Anyasome clinical efficacy is not clear, known as "golden oil", abuse of the god medicine, will be obviously limited use, and these performance appraisal indicators will also be the third-level hospital clinical drug use constraintsOn July 1,, the National Health and Care Commission released an important document, "Notice on the 2018 National Monitoring and Analysis of the Performance Review of The Third Level public Hospitals" (hereinafter referred to as the "Circular")it is understood that, according to the Opinions of the General Office of the State Council on Strengthening the Performance Evaluation of Three-Level Public Hospitals, 26 performance appraisal monitoring indicators were analyzed in 2019 by the Joint Relevant Departments of the National Health and Care Commission, based on the 2018 data of the national tertiary public hospitalsThe national monitoring and analysis (Western medicine level III public hospitals) is now communicatedthe above-mentioned document dates back to January 30, 2019, the General Office of the State Council issued the "Opinions of the General Office of the State Council on Strengthening the Performance Review of Three-Level Public Hospitals."the same day, the Director General of the Medical Administration and Hospital Authority Zhang Zongju at the State Council Information Office held a regular briefing on the State Council policy, said that the performance appraisal, the use of reasonable drug indicators instead of the proportion of single use of drugs for assessment, the reasonableness of each prescription of medical personnel and the quality and safety of patients' medication in a more prominent position, the relevant indicators to be assessedby the end of 2018, there are 2,398 tertiary public hospitals (of which 1,289 are general hospitals, 576 are specialized hospitals and 533 are Chinese medicine hospitals) to participate in the 2018 annual performance appraisalFor the first time, the Tianhe 2 supercomputer of the National Supercomputing Guangzhou Center used the big data collection of performance appraisal to calculate and analyze, and organized more than 100 disease, financial, clinical and management experts to carry out artificial quality control, which strongly guaranteed the true objectivity and fairness of the performance appraisal resultsthis time, the National Health and Care Commission for the first time to inform the relevant data, or the next performance appraisal indicators for the implementation and clinical drug use to play a guiding and normative roleAccording to the "National Health and Health Commission" issued by the National Health and Health Commission", the National Health and Health Commission Office on the issuance of the National Three-level Public Hospital Performance Assessment Manual (2019 version) of the entire indicator system, including the performance appraisal of the third-level public hospitals, including 4 first-level indicators, 14 secondary indicators, 55 tertiary indicators (quantitative 50, qualitative 5), there are nearly 10 indicators, highly related to the use of drugs in tertiary hospitals, for these indicators, the Health and Health Commission has given a gradual decline or rise of the guiding requirements, such as:the number of patients transferred (door emergency, hospitalization) graduallyincreased; Drug use intensity (DDDs) decreased gradually, the proportion of basic drug prescriptions for outpatients gradually increased, the proportion of winning drugs used in the centralized procurement of drugs by state organizations gradually increased, the proportion of supplementary drug use income of was monitored, the increase in the cost of the average drug in the outpatient sand." from this performance appraisal data, the performance of the above indicators are gradually better The effect of the construction of the -graded diagnosis and treatment system is gradually apparent From 2016 to 2018, the number of emergency and inpatient referrals in tertiary public hospitals increased year by year, with the number of patients transferred to the second-level hospitals or primary medical institutions in the Medical Association reached 1301.73 million in 2018, an increase of 45.45 percent over 2016, and the number of outpatients and discharges decreased, and the downward referral of suitable patients became a trend clinical drug use is more rational: in 2018, the use strength of antimicrobial drugs in tertiary public hospitals in China was about 37.78DDDs, which is better than the national requirements of 40DDDs in addition, the proportion of prescriptions for review, ward (district) medical orders (prescriptions) review rate, the number and proportion of essential drug procurement varieties increased year by year, the proportion of prescriptions for essential drugs for outpatients reached 52.25% (this indicator refers to the proportion of prescriptions with essential drugs to total prescriptions), and the proportion of inpatients with essential drugs The utilization rate reached 95.38% (this indicator refers to the proportion of the number of patients who contain essential drugs during hospitalization to the total number of discharges), and the proportion of the use of the winning drugs in the centralized procurement of drugs by state organizations reached 92.21% (the ratio of the amount of the winning drugs used by the state in the state centrally purchased by the hospital and the amount of the same drug used during the same period) the increase in medical expenses has stabilized Compared with 2016, the average cost of outpatient visits and hospitalizations in the third-tier public hospitals increased in 2018 (9.36 percent and 6.03 percent, respectively), the growth rate slowed and was lower than the GDP growth in the same year, and the cost of hospital-to-hospital drugs and outpatient s/out-patient drug costs decreased (down 15.25 percent and 3.38 percent, respectively), reflecting the overall steady trend of increase in the cost of medicinein in the tertiary public hospitals, and the unreasonable growth control at the same time, the income and expenditure structure of the three-level public hospitals has been continuously optimized, on the one hand, the proportion of medical services income (excluding drugs, supplies, inspection and inspection income) as a proportion of medical income, personnel expenditure as a proportion of business expenditure, income and expenditure balance has steadily increased; through performance appraisal, the final report card of 2398 three-level public hospitals shows that there are still some problems, such as the national three-level public hospital development imbalance, inadequate problem is more obvious: the monitoring analysis results of the third-level public hospitals mainly concentrated in Beijing, Shanghai, Zhejiang Province, Sichuan Province and other places, monitoring and analysis results are concentrated in Heilongjiang Province, Liaoning Province and Inner Mongolia Autonomous Region the problem of hospital admissions still exists across provinces, analyzing the first page data of the national tertiary public hospitals from 2016 to 2018, and the number of patients in the third-tier public hospitals in 2018 was higher than in 2016 and 2017 The provinces with the largest number of patients were Anhui, Hebei, Jiangsu, Zhejiang and Henan it is understood that the top 5 provinces with the largest inflows of patients are Shanghai, Beijing, Jiangsu, Guangdong and Zhejiang provinces, accounting for 53.6% of all the patients who are treated in different places The large influx of off-site patients also poses some challenges to medical services in Beijing and Shanghai this "circular" clearly, the next step, the National Health and Health Commission will continue to work with relevant departments to strengthen the performance appraisal work of thinking and summary, continuous improvement and gradually improve the performance appraisal system of public hospitals, give full play to the performance appraisal of public hospitals "command inglis" role, guide the country's second and third-level public hospitals to effectively improve the overall quality and management level of health care noteworthy, on June 9, the National Health and Care Commission issued a "Notice on the collection of 2019 performance appraisal data of secondary and tertiary public hospitals." three-level public hospitals should report data on the performance appraisal management platform of public hospitals from June 12 to June 19, 2020 The level 2 public hospitals participating in the 2019 Performance Review should report the data on the management platform from July 20 to August 5, 2020 notice is clear, it is strictly prohibited to fabricate, falsely report, underreport data and other circumstances The National Health and Health Commission will work with the relevant departments to organize experts to review and analyze the data, and seriously deal with the units and individuals that have deliberately fabricated, misrepresented, concealed and other violations of discipline in the course of the examination the performance appraisal operation manual issued by the National Health and Care Commission, the same key monitoring of drug revenue ratio, auxiliary drug revenue ratio, antibacterial drug use intensity (DDDs) and other indicators, which will be related to the clinical abuse of the norms and rectification, promote rational drug use industry has the view that performance is a baton, bull nose and navigation, only to establish an effective performance appraisal system, in order to better guide public hospitals towards the desired results As this assessment system, there are 26 indicators are national monitoring indicators, of which 15 can be directly crawled through the system, do not need to fill in After the hospital's clinical drug use, operation will be directly presented on the national system, national ranking, real-time online, because can not be false, true and credible, can be said to be the most rigorous assessment in this context, some clinical efficacy is not clear, known as "wanjin oil", abuse of the god medicine, will be obviously limited use, and these performance appraisal indicators will also be the three-level hospital clinical drug use constraints.